Today’s AI Top Pick: QXO
7/14/2026 · Contrarian screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live QXO price forecast →
QXO is the cleanest contrarian bounce setup in this pool: every single timeframe (1h/4h/1d/1wk) has a positive forecast (short/mid/long = +21.3/+28.0/+31.2% on 1h, +24.3/+36.8/+34.0% on 4h, +25.7/+43.9/+38.7% on 1d, +17.9/+20.1/+19.5% on 1wk) with bullish probability 1.0 and near-term bullish 1.0. Unlike names like BTAI, IONQ, TGEN, LGCL and EOSE — where the weekly forecast turns sharply negative and undercuts the daily bounce — QXO's weekly is still up, meaning the model sees a real trend repair, not just a dead-cat. Position in the 21-bar range is 0.25–2.3% across timeframes with a -22.7% daily drawdown and -44.4% weekly drawdown. That's textbook 'exhausted selling not making fresh new lows on the intraday' — the 1h is only -4.7% off its 21-bar high while the daily/weekly damage is done, which is exactly the microstructure you want on a dip buy. RSI 33.5 is oversold but not distressed. Contrast this with SSTK (Getty deal terminated 7/7, structurally impaired), MBRX (trial data missed significance, -25%), ALEC (GSK ended the partnership 7/9), FABC (187M share resale prospectus filed), ILLR (Nasdaq halt, reverse split, name change), and CALC (dilution overhang) — every one of those forecasts is undercut by a landmine headline. Fundamentals are the best in the field (fundamental_score 4.0): PEG 0.38, fwdPe 19.85, sales YoY 15,198% (roll-up strategy executing), institutional ownership 90.8%, analyst recom 1.14 (Strong Buy), and targetUpsidePct 117.2%. Fresh news is supportive: Citigroup (7/13) reiterated Buy at $25 PT, RBC (7/10) reiterated Outperform at $27, and Yahoo published 'Stock Looks Discounted Against Its Sales Base' 7/10 — analyst PT cuts were modest re-rates, not sell-side capitulation. Market cap $14.4B means this isn't a micro-cap lottery ticket like ANY, GELS, or BCDA. Why today and not later? The 1h is already curling up (fc_short +21%) with price pinned near the low of its 21-bar range — you get the bounce math without paying up. Waiting for a weekly base is unnecessary because the daily forecast is already the second-highest of the analyst-supported names, and if the Citi/RBC $25–27 targets are even directionally right, you're buying at ~52% of consensus fair value with confirmed multi-TF signal.
- Weekly forecast magnitude is modest (+17.9/+20.1/+19.5%) — implies grinding bounce, not a moonshot, so opportunity cost vs. higher-beta names is real
- Roll-up execution risk: profitMargin -7.38% and operMargin -4.03% — QXO is still burning while integrating; a bad quarter kills the peg 0.38 narrative
- Short float 24.9% is elevated — can accelerate both directions; a sector rug in industrials would hit hard
- Two consecutive analyst PT cuts (Citi to $25, Stifel-adjacent moves) show sell-side is trimming even while maintaining Buy — momentum in estimates is negative
- -44.4% weekly drawdown means overhead supply from $18–24 is thick; expect resistance and possible false breakouts before a clean base forms
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | QXO | BUY NOW | 8.4 | All 4 TFs up, best fundamentals in pool (PEG 0.38, recom 1.14), analysts reiterating Buy at $25–27, position 0-2% in range. |
| 2 | NEOV | BUY NOW | 7.6 | Clean 4-TF alignment, strong 1d/1wk forecasts, salesYoY 324%, positive recent narrative on utility-scale pivot. |
| 3 | IMSR | BUY NOW | 7.3 | All available TFs positive with +80%+ 1d fc_mid/long, recom 1.0, oversold RSI 32.6, cash-backed nuclear SMR story. |
| 4 | CWH | BUY PULLBACK | 7.0 | 4-TF aligned bounce, PEG 0.05, fwdPe 5.51, but debtEq 19.03 and multiple recent bearish articles cap conviction. |
| 5 | GRML | BUY PULLBACK | 6.7 | 3-TF up with 1d fc_long +104%, SRX strategic investment; micro-cap illiquidity is the risk. |
| 6 | GTBP | BUY PULLBACK | 6.5 | Clean multi-TF bounce off shallow drawdown, no landmine headlines, but fundamentals thin. |
| 7 | FRSX | BUY PULLBACK | 6.4 | 4-TF aligned with 1d fc_long +69%, position 0-4.9% in range; micro-cap execution risk. |
| 8 | OPTU | BUY PULLBACK | 6.3 | 1d fc_mid +90.8%, 1wk fc_short +21.3%, but recom 3.54 is a red flag and coverage is thin. |
| 9 | ANY | BUY PULLBACK | 6.2 | 3-TF up with 1d fc_mid +130%, DarkHorse rebrand catalyst; but $12.6M cap and thin institutional ownership. |
| 10 | CNTN | BUY PULLBACK | 6.1 | Only 2 TFs available but both up, perfYear +31% is unique in this pool of losers, Russell 3000 inclusion. |
| 11 | HOME-USD | BUY PULLBACK | 6.0 | Crypto with all TFs up (1d fc_mid +83%), no fundamentals to judge, purely a bounce trade. |
| 12 | BCDA | BUY PULLBACK | 5.8 | Explosive 1wk fc (+94/+203/+241%) but 1h fc_short -4.9% suggests today isn't the entry. |
| 13 | FLYX | BUY PULLBACK | 5.7 | All TFs up, Jet.AI merger closed 7/7 as a catalyst, but 1h fc_long fades and float dynamics unclear. |
| 14 | CALC | BUY PULLBACK | 5.6 | Massive 1d fc (+77/+231/+214%) and FDA clears Auxora, but $49M PIPE dilution is a headwind. |
| 15 | ARQQ | WAIT | 5.4 | 1h fc negative (-1.6/-13.8%) and PS 287.7 is extreme; wait for the near-term to turn. |
| 16 | MBRX | WAIT | 5.2 | Strong forecast but MIRACLE trial data missed significance 6/30, hard to buy into that. |
| 17 | IONQ | WAIT | 5.0 | Weekly forecast is -4/-38/-79% — model sees this bounce as a lower-high in a broken weekly trend. |
| 18 | QBTS | WAIT | 4.9 | Data truncated in feed, PS 555 is extreme, fundamental_score -1.75, quantum name at high beta. |
| 19 | EOSE | WAIT | 4.7 | Capital raise triggered 2 PT cuts 7/13, 1d fc_short is -2.6%, near-term momentum broken. |
| 20 | TGEN | WAIT | 4.5 | 1wk forecast is -14.6/-35.9/-51.5% and 'fair value cut' 6/27; positive orders don't outweigh the weekly bear signal. |
| 21 | LGCL | WAIT | 4.2 | 1wk fc -36% and short interest surging with shortFloat 142.75%; setup screams squeeze-or-implode, not clean dip buy. |
| 22 | GELS | WAIT | 4.1 | 1h fc negative (-6.1/-8.2%), profitMargin -4350%, micro-cap $5.8M — too fragile. |
| 23 | BTAI | AVOID | 3.8 | 1wk forecast -53% flat across horizons and price at 95% of 1h range — chasing the top of a broken chart. |
| 24 | RR | AVOID | 3.5 | Just plummeted to 52-week lows 7/14, PS 73, profitMargin -417%; contrarian yes, but knife-catch territory. |
| 25 | FABC | AVOID | 3.2 | Filed resale prospectus for 187.2M shares 7/2 — massive dilution overhang undercuts the forecast. |
| 26 | ALEC | AVOID | 3.0 | GSK ended the brain-drug alliance 7/9 — the fundamental thesis is broken regardless of the model bounce. |
| 27 | SSTK | AVOID | 2.8 | Getty $3.7B merger terminated 7/7 by UK CMA — deal-break is why it's down; forecast doesn't know the news. |
| 28 | BIRD | AVOID | 2.5 | Fundamental_score -3, position at 98% of 1h range (chasing), and 1wk fc_mid/long turn negative. |
| 29 | ILLR | AVOID | 1.8 | Nasdaq halted the stock 6/30, reverse-split authorized, name changing to Eight Holdings — untradeable landmine. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord